{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:45:25Z","timestamp":1787964325903,"version":"build-2784847793"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1681\/asn.2011010045","type":"journal-article","created":{"date-parts":[[2011,9,24]],"date-time":"2011-09-24T03:26:32Z","timestamp":1316834792000},"page":"2016-2027","source":"Crossref","is-referenced-by-count":47,"title":["Mdm2 Promotes Systemic Lupus Erythematosus and Lupus Nephritis"],"prefix":"10.1681","volume":"22","author":[{"given":"Ramanjaneyulu","family":"Allam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufyan G.","family":"Sayyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar P.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lichtnekert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20230423","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"key":"R2-10-20230423","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"R3-10-20230423","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.immunol.021908.132653","article-title":"Recent advances in the genetics of autoimmune disease","volume":"27","author":"Gregersen","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"R4-10-20230423","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.molmed.2009.10.004","article-title":"Pseudoviral immunity\u2014A novel concept for lupus","volume":"15","author":"Anders","year":"2009","journal-title":"Trends Mol Med"},{"key":"R5-10-20230423","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.immunol.22.012703.104514","article-title":"Immunologically active autoantigens: The role of toll-like receptors in the development of chronic inflammatory disease","volume":"25","author":"Marshak-Rothstein","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"R6-10-20230423","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/eji.200838478","article-title":"Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus","volume":"38","author":"Anders","year":"2008","journal-title":"Eur J Immunol"},{"key":"R7-10-20230423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2710","article-title":"DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr\/lpr mice in vivo","volume":"11","author":"Lenert","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R8-10-20230423","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1681\/ASN.2005060658","article-title":"G-rich DNA suppresses systemic lupus","volume":"16","author":"Patole","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R9-10-20230423","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2006101162","article-title":"Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus","volume":"18","author":"Pawar","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R10-10-20230423","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1681\/ASN.2008101067","article-title":"Viral RNA and DNA trigger common antiviral responses in mesangial cells","volume":"20","author":"Allam","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R11-10-20230423","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/eji.200838604","article-title":"Viral 5\u2032-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses","volume":"38","author":"Allam","year":"2008","journal-title":"Eur J Immunol"},{"key":"R12-10-20230423","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1096\/fj.03-0646fje","article-title":"Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice","volume":"18","author":"Anders","year":"2004","journal-title":"FASEB J"},{"key":"R13-10-20230423","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1681\/ASN.2005070714","article-title":"Toll-like receptor-7 modulates immune complex glomerulonephritis","volume":"17","author":"Pawar","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R14-10-20230423","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"R15-10-20230423","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"R16-10-20230423","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","article-title":"Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53","volume":"420","author":"Honda","year":"1997","journal-title":"FEBS Lett"},{"key":"R17-10-20230423","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07986","article-title":"Cytoplasmic functions of the tumour suppressor p53","volume":"458","author":"Green","year":"2009","journal-title":"Nature"},{"key":"R18-10-20230423","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nrd2656","article-title":"The genetics of the p53 pathway, apoptosis and cancer therapy","volume":"7","author":"Vazquez","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"R19-10-20230423","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1128\/JVI.01681-08","article-title":"MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival","volume":"83","author":"Forte","year":"2009","journal-title":"J Virol"},{"key":"R20-10-20230423","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.iy.09.040191.001331","article-title":"Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease","volume":"9","author":"Cohen","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"R21-10-20230423","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"R22-10-20230423","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1084\/jem.165.3.750","article-title":"Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus","volume":"165","author":"Reeves","year":"1987","journal-title":"J Exp Med"},{"key":"R23-10-20230423","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat Med"},{"key":"R24-10-20230423","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.immunol.24.021605.090513","article-title":"Genetic disorders of programmed cell death in the immune system","volume":"24","author":"Bidere","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"R25-10-20230423","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0092-8674(00)81108-3","article-title":"Systemic lupus erythematosus","volume":"85","author":"Kotzin","year":"1996","journal-title":"Cell"},{"key":"R26-10-20230423","doi-asserted-by":"crossref","first-page":"14973","DOI":"10.1073\/pnas.96.26.14973","article-title":"Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage","volume":"96","author":"Khosravi","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-10-20230423","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R28-10-20230423","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/dmd.110.035915","article-title":"Whole-body physiologically based pharmacokinetic model for nutlin-3a in mice after intravenous and oral administration","volume":"39","author":"Zhang","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"R29-10-20230423","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"R30-10-20230423","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJMra0901217","article-title":"Cell death","volume":"361","author":"Hotchkiss","year":"2009","journal-title":"N Engl J Med"},{"key":"R31-10-20230423","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virol.2008.09.034","article-title":"The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53","volume":"384","author":"Levine","year":"2009","journal-title":"Virology"},{"key":"R32-10-20230423","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1172\/JCI30945","article-title":"Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas","volume":"117","author":"Sarek","year":"2007","journal-title":"J Clin Invest"},{"key":"R33-10-20230423","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1182\/blood-2005-08-3273","article-title":"MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells","volume":"107","author":"Coll-Mulet","year":"2006","journal-title":"Blood"},{"key":"R34-10-20230423","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.pharmtox.48.113006.094723","article-title":"Small-molecule inhibitors of the MDM2\u2013p53 protein-protein interaction to reactivate p53 function: A novel approach for cancer therapy","volume":"49","author":"Shangary","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R35-10-20230423","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molmed.2006.11.002","article-title":"MDM2 inhibitors for cancer therapy","volume":"13","author":"Vassilev","year":"2007","journal-title":"Trends Mol Med"},{"key":"R36-10-20230423","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nri2527","article-title":"Antiviral immune responses: Triggers of or triggered by autoimmunity?","volume":"9","author":"Munz","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"R37-10-20230423","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature09102","article-title":"TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus","volume":"465","author":"Guiducci","year":"2010","journal-title":"Nature"},{"key":"R38-10-20230423","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"R39-10-20230423","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.2353\/ajpath.2010.091227","article-title":"4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice","volume":"176","author":"Kulkarni","year":"2010","journal-title":"Am J Pathol"},{"key":"R40-10-20230423","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/eji.1830200812","article-title":"Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs: Minimal estimates of production and turnover rates of mature lymphocytes","volume":"20","author":"Rocha","year":"1990","journal-title":"Eur J Immunol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201111000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:21:01Z","timestamp":1786130461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201111000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2011010045","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}